Protagonist Therapeutics, Inc (PTGX) › RevenueProtagonist Therapeutics, Inc (PTGX) — RevenueAnnual figures by fiscal year, from SEC filings.2017: $20.06M2018: $30.93M2019: $231.0K2020: $28.63M2021: $27.36M2022: $26.58M2023: $60.00M2024: $434.43M2025: $46.02M$46.02M2017Revenue (USD)2025Fiscal YearRevenueChange YoY2025$46.02M-89.4%2024$434.43M+624.1%2023$60.00M+125.7%2022$26.58M-2.8%2021$27.36M-4.4%2020$28.63M+12293.1%2019$231.0K-99.3%2018$30.93M+54.1%2017$20.06M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share